Introduction: Tuberculosis is closely linked to poverty, with patients facing significant indirect treatment costs. Treating drug-resistant tuberculosis further increases these expenses. Notably, there is a lack of published data on the indirect costs incurred by patients with drug-resistant tuberculosis in Mozambique. Objective: To assess the indirect costs, income reduction, and work productivity incurred by patients undergoing diagnosis and treatment for Drug-Resistant Tuberculosis (DRTB) in Mozambique during their TB treatment. Methods: As part of a comprehensive mixed-methods study conducted from January 2021 to April 2023, this research utilized a descriptive cross-sectional approach, incorporating both quantitative and qualitative methods. The primary goal was to evaluate the costs incurred by the national health system due to drug-resistant TB. Additionally, to explore the indirect costs experienced by patients and their families during treatment, semi-structured interviews were conducted with 27 individuals who had been undergoing treatment for over six months. Results: All survey participants unanimously reported a significant decline in labour productivity, with 70.3% experiencing a reduction in their monthly income. Before falling ill, the majority of respondents (33.3%) earned up to $76.92 monthly, representing the minimum earnings range, while 29.2% had a monthly income above $230.77, the maximum earnings range. Among those who experienced income loss, the majority (22.2%) reported a decrease of up to $76.92 per month, and 18.5% cited a loss exceeding $230.77 per month. Notably, patients with Drug-Resistant Tuberculosis (DRTB) have not incurred the direct costs of the disease, as these are covered by the government. Conclusion: The financial burden of treating Drug-Resistant Tuberculosis (DRTB), along with the income reduction it causes, is substantial. Implementing a patient-centred, multidisciplinary, and multisector approach, coupled with strong psychosocial support, can significantly reduce the catastrophic costs DRTB patients incur.
References
[1]
World Health Organization (2023) WHO Global Tuberculosis Report 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022
[2]
Monedero-Recuero, I., Gegia, M., Wares, D.F., Chadha, S.S. and Mirzayev, F. (2021) Situational Analysis of 10 Countries with a High Burden of Drug-Resistant Tuberculosis 2 Years Post-UNHLM Declaration: Progress and Setbacks in a Changing Landscape. International Journal of Infectious Diseases, 108, 557-567. https://doi.org/10.1016/j.ijid.2021.06.022
[3]
TDR (2023) Exploring Catastrophic Household Costs for Tuberculosis Treatment. https://tdr.who.int/newsroom/news/item/29-06-2023-exploring-catastrophic-household-costs-for-tuberculosis-treatment
[4]
World Health Organization (2023) WHO Releases New Global Lists of High-Burden Countries for TB, HIV-Associated TB and Drug-Resistant TB. https://www.who.int/news/item/17-06-2021-who-releases-new-global-lists-of-high-burden-countries-for-tb-hiv-associated-tb-and-drug-resistant-tb
[5]
UNFPA United Nations Population Fund (2023) World Population Dashboard Mozambique. https://www.unfpa.org/data/world-population/MZ
[6]
UNDP (2023) Unstacking Global Poverty: Data for High Impact Action: Briefing Note for Countries on the 2023 Multidimensional Poverty Index—Mozambique. https://hdr.undp.org/sites/default/files/Country-Profiles/MPI/MOZ.pdf
Oxlade, O. and Murray, M. (2012) Tuberculosis and Poverty: Why Are the Poor at Greater Risk in India? PLOS ONE, 7, e47533. https://doi.org/10.1371/journal.pone.0047533
[9]
Moutinho, S. (2022) Tuberculosis Is the Oldest Pandemic, and Poverty Makes It Continue. Nature, 605, S16-S20. https://doi.org/10.1038/d41586-022-01348-0
[10]
Barter, D.M., Agboola, S.O., Murray, M.B. and Bärnighausen, T. (2012) Tuberculosis and Poverty: The Contribution of Patient Costs in Sub-Saharan Africa—A Systematic Review. BMC Public Health, 12, Article 980. https://doi.org/10.1186/1471-2458-12-980
[11]
Muttamba, W., Tumwebaze, R., Mugenyi, L., Batte, C., Sekibira, R., Nkolo, A., et al. (2020) Households Experiencing Catastrophic Costs Due to Tuberculosis in Uganda: Magnitude and Cost Drivers. BMC Public Health, 20, Article 1409. https://doi.org/10.1186/s12889-020-09524-5
[12]
World Health Organization (2021) The End TB Strategy. https://www.who.int/teams/global-tuberculosis-programme/the-end-tb-strategy
[13]
PNCT (2021) Relatório Anual do Programa. Misau, Maputo.
[14]
Bardin, L. (2023) Análise de Conteúdo. 70th Edition, Presses Universitaires de France, Paris, 225. https://edisciplinas.usp.br/pluginfile.php/7684991/mod_resource/content/1/BARDlN__L._1977._Analise_de_conteudo._Lisboa__edicoes__70__225.20191102-5693-11evk0e-with-cover-page-v2.pdf
[15]
Lisboa, O. (2023) Civil Service Minimum Wage Doubles in Mozambique. RFI, Mozambique. https://www.rfi.fr/pt/mo%C3%A7ambique/20230118-salário-mínimo-da-fun%C3%A7%C3%A3o-pública-duplica-em-mo%C3%A7ambique
[16]
Sharma, S.K. and Mohan, A. (2006) Multidrug-Resistant Tuberculosis: A Menace that Threatens to Destabilize Tuberculosis Control. Chest, 130, 261-272. https://doi.org/10.1016/S0012-3692(15)50981-1
[17]
Ferreira, K.R., Orlandi, G.M., Da Silva, T.C, Bertolozzi, M.R., De Siqueira França, F.O. and Bender, A. (2018) Representations on Adherence to the Treatment of Multidrug-Resistant Tuberculosis. Revista da Escola de Enfermagem da USP, 52, e03412. https://doi.org/10.1590/s1980-220x2018010303412
[18]
Ghazy, R.M., Sallam, M., Ashmawy, R., Elzorkany, A.M., Reyad, O.A., Hamdy, N.A., et al. (2023) Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies. International Journal of Environmental Research and Public Health,20, Article 2640. https://doi.org/10.3390/ijerph20032640
[19]
Kilale, A.M., Pantoja, A., Jani, B., Range, N., Ngowi, B.J., Makasi, C., et al. (2022) Economic Burden of Tuberculosis in Tanzania: A National Survey of Costs Faced by Tuberculosis-Affected Households. BMC Public Health, 22, Article No. 600. https://doi.org/10.1186/s12889-022-12987-3
[20]
PNCT (2021) Manual do Manejo Clinico e Programatico da Tuberculose Multiresistente. Misau.
[21]
De Lima Orofino, R., Do Brasil, P.E.A., Trajman, A., Schmaltz, C.A.S., Dalcolmo, M. and Rolla, V.C. (2012) Preditores dos Desfechos do Tratamento da Tuberculose. Jornal Brasileiro de Pneumologia, 38, 88-97. https://doi.org/10.1590/S1806-37132012000100013
[22]
Tanimura, T., Jaramillo, E., Weil, D., Raviglione, M. and Lönnroth, K. (2014) Financial Burden for Tuberculosis Patients in Low-and Middle-Income Countries: A Systematic Review. European Respiratory Journal, 43, 1763-1775. https://doi.org/10.1183/09031936.00193413
[23]
Arante, E. (2023) Poverty Rate Soared in Mozambique-O País. Club of Mozambique, Maputo. https://clubofmozambique.com/news/poverty-rate-soared-in-mozambique-o-pais-145005/
[24]
Foster, N., Vassall, A., Cleary, S., Cunnama, L., Churchyard, G. and Sinanovic, E. (2015) The Economic Burden of TB Diagnosis and Treatment in South Africa. Social Science & Medicine, 130, 42-50. https://doi.org/10.1016/j.socscimed.2015.01.046
[25]
Jiang, W.-X., et al. (2021) Impacts of a Comprehensive Tuberculosis Control Model on the Quality of Clinical Services and the Financial Burden of Treatment for Patients with Drug-Resistant Tuberculosis in China: A Mixed-Methods Evaluation. Infectious Diseases of Poverty, 10, Article No. 54. https://doi.org/10.1186/s40249-021-00832-5
[26]
Baral, S.C., Aryal, Y., Bhattrai, R., King, R. and Newell, J.N. (2014) The Importance of Providing Counselling and Financial Support to Patients Receiving Treatment for Multi-Drug Resistant TB: Mixed Method Qualitative and Pilot Intervention Studies. BMC Public Health, 14, Article No. 46. https://doi.org/10.1186/1471-2458-14-46
[27]
Sayem, M., Hossain, M., Ahmed, T., Hossain, K. and Saud, Z. (2020) Effect of Nutritional Support on Treatment of Multi-Drug Resistant Tuberculosis in Rajshahi Division, Bangladesh. Journal of Tuberculosis Research, 8, 223-236. https://doi.org/10.4236/jtr.2020.84020
[28]
Baluku, J.B., Namiiro, S., Nabwana, M., Muttamba, W. and Kirenga, B. (2021) Undernutrition and Treatment Success in Drug-Resistant Tuberculosis in Uganda. Infection and Drug Resistance, 14, 3673-3681. https://doi.org/10.2147/IDR.S332148
[29]
Wagnew, F., Gray, D., Tsheten, T., Kelly, M., Clements, A.C.A. and Alene, K.A. (2023) Effectiveness of Nutritional Support to Improve Treatment Adherence in Patients with Tuberculosis: A Systematic Review. Nutrition Reviews, Article nuad120. https://doi.org/10.1093/nutrit/nuad120
[30]
Long, Q., Qu, Y. and Lucas, H. (2016) Drug-Resistant Tuberculosis Control in China: Progress and Challenges. Infectious Diseases of Poverty, 5, Article No. 9. https://doi.org/10.1186/s40249-016-0103-3
[31]
Li, R., et al. (2015) Effect of a Comprehensive Programme to Provide Universal Access to Care for Sputum-Smear-Positive Multidrug-Resistant Tuberculosis in China: A Before-and-After Study. The Lancet Global Health, 3, E217-E228. https://doi.org/10.1016/S2214-109X(15)70021-5
